Skip to main content
Topics
Video
Provider
Payer
Pharma
ANZ
ASIA
EMEA
Global Edition
Disease Management
Bayer's equity investment and development commitments bring nearly $100M to One Drop
By
Dave Muoio
|
12:49 pm |
August 24, 2020
The data-driven blood glucose monitor system-maker will use the money to push into new areas of disease management, such as cardiology, oncology and women's health.